Published in Neurology on January 10, 2014
Treatment of neuromyelitis optica: state-of-the-art and emerging therapies. Nat Rev Neurol (2014) 1.53
Neuromyelitis optica spectrum disorders: An update. Ann Indian Acad Neurol (2015) 0.77
Autoantibody to MOG suggests two distinct clinical subtypes of NMOSD. Sci China Life Sci (2016) 0.76
A Case Study of Intractable Vomiting with Final Diagnosis of Neuromyelitis Optica. Case Rep Pediatr (2015) 0.75
Clinical Profile of Anti-Myelin Oligodendrocyte Glycoprotein Antibody Seropositive Cases of Optic Neuritis. Neuroophthalmology (2015) 0.75
Diagnostics of the neuromyelitis optica spectrum disorders (NMOSD). Neurol Sci (2017) 0.75
A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet (2004) 13.18
Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis. Brain (2007) 4.50
Brain abnormalities in neuromyelitis optica. Arch Neurol (2006) 4.28
Neuromyelitis optica and non organ-specific autoimmunity. Arch Neurol (2008) 3.95
Neuromyelitis optica brain lesions localized at sites of high aquaporin 4 expression. Arch Neurol (2006) 3.26
Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis. Ann Neurol (2006) 2.80
Not every patient with multiple sclerosis should be treated at time of diagnosis. Arch Neurol (2006) 2.67
Treatment of neuromyelitis optica with rituximab: retrospective analysis of 25 patients. Arch Neurol (2008) 2.58
Eculizumab in AQP4-IgG-positive relapsing neuromyelitis optica spectrum disorders: an open-label pilot study. Lancet Neurol (2013) 2.46
Updated estimate of AQP4-IgG serostatus and disability outcome in neuromyelitis optica. Neurology (2013) 2.34
Seizure prophylaxis in patients with brain tumors: a meta-analysis. Mayo Clin Proc (2004) 2.29
Diagnosis of neuromyelitis spectrum disorders: comparative sensitivities and specificities of immunohistochemical and immunoprecipitation assays. Arch Neurol (2009) 1.61
Epidemiology of neuromyelitis optica in the United States: a multicenter analysis. Arch Neurol (2012) 1.40
Neuromyelitis optica: changing concepts. J Neuroimmunol (2007) 1.39
Atraumatic lumbar puncture needles: after all these years, are we still missing the point? Neurologist (2009) 1.29
Treatment of neuromyelitis optica with mycophenolate mofetil: retrospective analysis of 24 patients. Arch Neurol (2009) 1.27
Clinical practice. Transverse myelitis. N Engl J Med (2010) 1.17
NMO-IgG: a specific biomarker for neuromyelitis optica. Dis Markers (2006) 1.14
Coexistence of myasthenia gravis and serological markers of neurological autoimmunity in neuromyelitis optica. Muscle Nerve (2009) 1.13
Neuromyelitis optica. Curr Opin Neurol (2007) 1.10
Effects of age and sex on aquaporin-4 autoimmunity. Arch Neurol (2012) 1.09
Smoking: effects on multiple sclerosis susceptibility and disease progression. Ther Adv Neurol Disord (2012) 1.08
Telemedicine versus telephone for remote emergency stroke consultations: a critically appraised topic. Neurologist (2009) 1.06
Sniffing out Parkinson disease: can olfactory testing differentiate parkinsonian disorders? Neurologist (2007) 0.98
Cerebrospinal fluid angiotensin-converting enzyme for diagnosis of central nervous system sarcoidosis. Neurologist (2009) 0.97
Clinical predictors of psychogenic nonepileptic seizures: a critically appraised topic. Neurologist (2008) 0.93
Disrupted daytime activity and altered sleep-wake patterns may predict transition to mild cognitive impairment or dementia: a critically appraised topic. Neurologist (2012) 0.90
New-onset atrial fibrillation in severe sepsis and risk of stroke and death: a critically appraised topic. Neurologist (2012) 0.89
"Idiopathic" rapid-eye-movement (REM) sleep behavior disorder is associated with future development of neurodegenerative diseases. Neurologist (2007) 0.86
Alpha-lipoic acid may improve symptomatic diabetic polyneuropathy. Neurologist (2007) 0.86
OSMS is NMO, but not MS: proven clinically and pathologically. Lancet Neurol (2006) 0.85
Does cervical manipulative therapy cause vertebral artery dissection and stroke? Neurologist (2008) 0.85
Risk of development of medication overuse headache with nonsteroidal anti-inflammatory drug therapy for migraine: a critically appraised topic. Neurologist (2011) 0.85
Adjunctive haloperidol prophylaxis reduces postoperative delirium severity and duration in at-risk elderly patients. Neurologist (2008) 0.84
Serum neuron specific enolase to predict neurological outcome after cardiopulmonary resuscitation: a critically appraised topic. Neurologist (2009) 0.84
Neuromyelitis optica spectrum disorders. Continuum (Minneap Minn) (2010) 0.84
Is dabigatran cost effective compared with warfarin for stroke prevention in atrial fibrillation? A critically appraised topic. Neurologist (2012) 0.83
Anticonvulsant drug therapy after aneurysmal subarachnoid hemorrhage: a critically appraised topic. Neurologist (2010) 0.83
Treatment of vascular dementia and vascular cognitive impairment. Neurologist (2007) 0.83
Caffeine for the prevention and treatment of postdural puncture headache: debunking the myth. Neurologist (2007) 0.82
The role of corticosteroids in the management of chronic subdural hematomas: a critically appraised topic. Neurologist (2009) 0.82
Early versus late antiepileptic drug withdrawal for people with epilepsy in remission. Cochrane Database Syst Rev (2015) 0.81
Is donepezil effective for multiple sclerosis-related cognitive dysfunction? A critically appraised topic. Neurologist (2012) 0.81
The clinical utility of high resolution magnetic resonance imaging in the diagnosis of giant cell arteritis: a critically appraised topic. Neurologist (2008) 0.81
Migraine with and without aura and risk for cardiovascular disease. Curr Atheroscler Rep (2008) 0.81
Establishing a diagnosis of benign paroxysmal positional vertigo through the dix-hallpike and side-lying maneuvers: a critically appraised topic. Neurologist (2008) 0.79
Acute transverse myelitis: is the "idiopathic" form vanishing? Neurology (2005) 0.79
Skin biopsy for diagnosis of small fiber neuropathy: a critically appraised topic. Neurologist (2010) 0.79
Timing of antiepileptic drug withdrawal in adult epilepsy patients after neocortical surgical resection: a critically appraised topic. Neurologist (2011) 0.79
The effect of selective serotonin reuptake inhibitors on the frequency of psychogenic nonepileptic seizures: a critically appraised topic. Neurologist (2013) 0.79
Second-generation antiepileptic drugs' impact on balance: a meta-analysis. Mayo Clin Proc (2007) 0.79
Are corticosteroid and antiviral treatments effective for bell palsy? A critically appraised topic. Neurologist (2010) 0.78
White matter disease: optimizing rituximab therapy for neuromyelitis optica. Nat Rev Neurol (2011) 0.78
Physical activity level and future risk of mild cognitive impairment or dementia: a critically appraised topic. Neurologist (2015) 0.78
Determination of hemispheric language dominance in the surgical epilepsy patient: diagnostic properties of functional magnetic resonance imaging. Neurologist (2012) 0.78
Japanese optic-spinal MS: is it MS or neuromyelitis optica and does the answer dictate treatment? Neurology (2010) 0.78
Efficacy of rivastigmine for cognitive symptoms in Parkinson disease with dementia. Neurologist (2009) 0.78
Effectiveness of adding memantine to an Alzheimer dementia treatment regimen which already includes stable donepezil therapy: a critically appraised topic. Neurologist (2011) 0.77
Therapeutic hypothermia for severe traumatic brain injury: a critically appraised topic. Neurologist (2012) 0.77
Autoimmune encephalopathy. Mayo Clin Proc (2010) 0.77
Are corticosteroids efficacious for preventing or treating neutralizing antibodies in multiple sclerosis patients treated with beta-interferons? A critically appraised topic. Neurologist (2010) 0.77
Critically appraised topics: the evidence-based neurologist. Neurologist (2007) 0.77
IFNβ-1b may severely exacerbate Japanese opticspinal MS in neuromyelitis optica spectrum: Japanese optic-spinal MS: is it MS or neuromyelitis optica and does the answer dictate treatment? Neurology (2011) 0.76
Spinal cord astrocytoma presenting as "idiopathic" intracranial hypertension. Clin Neurol Neurosurg (2005) 0.76
Does prophylactic postoperative hypervolemic therapy prevent cerebral vasospasm and improve clinical outcome after aneurysmal subarachnoid hemorrhage? Neurologist (2008) 0.75
Supplementing our understanding of vitamin D and multiple sclerosis. Neurology (2010) 0.75
Do antiepileptic drugs increase the risk of suicidality in adult patients with epilepsy?: a critically appraised topic. Neurologist (2010) 0.75
Lupus related longitudinal myelitis. J Rheumatol (2011) 0.75
"Response to the commentary on "neuromyelitis optica: potential roles for intravenous immunoglobulin"". J Clin Immunol (2012) 0.75
Amantadine for patients with severe traumatic brain injury: a critically appraised topic. Neurologist (2015) 0.75
Remission, intractability, and antiepileptic-drug withdrawal. Lancet Neurol (2005) 0.75
Is Intravenous Thrombolysis Safe and Effective in Central Retinal Artery Occlusion? A Critically Appraised Topic. Neurologist (2017) 0.75
Safety and efficacy of ultrasound-enhanced thrombolysis in the treatment of acute middle cerebral artery infarction: a critically appraised topic. Neurologist (2011) 0.75
The MERITs of evidence-based clinical practice in neurology. Semin Neurol (2007) 0.75
Do cannabinoids reduce multiple sclerosis-related spasticity? Neurologist (2009) 0.75
IVIG Versus PLEX in the Treatment of Worsening Myasthenia Gravis: What is the Evidence?: A Critically Appraised Topic. Neurologist (2015) 0.75
Surgical decompression improves mortality and morbidity after large territory acute cerebral infarction: a critically appraised topic. Neurologist (2011) 0.75